Protease inhibitors as potential disease-modifying therapeutics for Alzheimer's disease.


The current lack of an effective treatment for Alzheimer's disease (AD) has fuelled an intense search for novel therapies for this neurodegenerative condition. Aberrant production or decreased clearance of amyloid-beta peptides is widely accepted to be causative for AD. Amyloid-beta peptides are produced by sequential processing of the beta-amyloid… (More)


  • Presentations referencing similar topics